Mechanism of tumor immune escape during p53 inactivation

 16
Mechanism of tumor immune escape during p53 inactivation

How p53 modulates the immune landscape for immune escape remains elusive.

The researchers report that Il34 is a gene transcriptionally repressed by p53, and p53 loss resulted in IL-34 secretion by cancer stem cells (CSCs). 

They also show that IL-34-acts via CD36-axis-to activate tumor associated macrophages (TAMs) to  promote tumor immune escape by suppressing T cell-mediated antitumor immunity.

When authors blocked IL-34-CD36 axis, it elicited antitumor immunity that synergized with anti-PD-1 immunotherapy, leading to a complete response.

https://www.cell.com/immunity/fulltext/S1074-7613(24)00415-1

https://sciencemission.com/Interleukin-34-orchestrated-tumor-associated-macrophage-reprogramming-is-required-for-tumor-immune-escape-driven-by-p53-inactivation